<- Back to digest

JOA - 2026-11-01 - Journal Article; Comparative Study

Dual Mobility versus Jumbo Head (≥ 40 mm) Following Primary Total Hip Arthroplasty: A Registry-Based Cohort Study.

Chen F, Prentice HA, Fasig BH, Paxton EW, Khatod M, Okike KM

retrospective cohortLOE IIIn = 9,532 (1,716 DM; 7,816 JH)Up to 6 years (registry-based, variable follow-up with inflection point at 4.25 years)

Topics

arthroplasty
PMID: 41780831DOI: 10.1016/j.arth.2026.02.038View on PubMed ->

Key Takeaway

Dual mobility reduces early dislocation risk vs jumbo head (HR 0.52 before 4.25 years) but carries significantly higher late dislocation risk (HR 8.26 after 4.25 years), with no difference in revision rates at 6 years.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This US registry-based cohort compared dislocation and revision outcomes between dual mobility and jumbo head (≥40 mm) constructs in primary THA from 2010–2024, using propensity score-weighted Cox regression and restricting inclusion to acetabular shells compatible with both options to reduce confounding. Six-year dislocation incidence was nearly identical (DM 2.4% vs JH 2.2%), but DM conferred a 48% reduction in early dislocation risk (HR 0.52) and an 8-fold increase in late dislocation risk (HR 8.26) beyond 4.25 years. No statistically significant differences were found in all-cause revision (HR 1.22), aseptic revision (HR 1.47), or instability-related revision (HR 1.71).

Key Limitation

The late dislocation hazard ratio (8.26) is derived from a small number of events after 4.25 years, rendering this estimate statistically fragile and potentially misleading for clinical decision-making.

Original Abstract

BACKGROUND

Instability remains a leading complication following primary total hip arthroplasty (THA). Large articulations enhance stability by increasing jump distance and range of motion. Dual mobility (DM) and ≥ 40 mm jumbo heads (JHs) are both large articulation options when compared to ≤ 36 mm heads, and debate exists between these two given differences in complexity, cost, and failure mechanism.

METHODS

We conducted a united States registry-based cohort study to compare DM and JH. Adults who underwent primary THA between 2010 and 2024 were included. There were 9,532 TH As (1,716 DMs and 7,816 J Hs) included. To mitigate confounding by indication and by implant generation, only cases that used DM or JH with acetabular implants compatible with both options were included. The primary outcome was dislocation; secondary outcomes were all-cause revision, aseptic revision, and revision for instability. Crude incidence was calculated at six years. Propensity score-weighted Cox proportional hazards regressions were used to evaluate revision risk.

RESULTS

Dislocation incidence was 2.4 and 2.2% for DMs and JHs, respectively. We observed a time-based difference in dislocation risk: DM was associated with a lower risk before 4.25 years (hazard ratio (HR): 0.52, 95% confidence interval (CI): 0.32 to 0.85), but a higher risk after 4.25 years (HR: 8.26, 95% CI: 1.82 to 37.48). There were no differences found in all-cause (HR: 1.22, 95% CI: 0.72 to 2.07), aseptic (HR: 1.47, 95% CI: 0.73 to 2.93), or instability-related revision risk (HR: 1.71, 95% CI: 0.79 to 3.69).

CONCLUSIONS

Use of a DM was associated with fewer early dislocations, but possibly more late dislocations, although late differences were small and later follow-up was limited. There was also no detectable difference in revisions, including for instability. While DM's marginal size advantage may avoid a small number of early closed dislocations, current large articulation options may be sufficiently similar to mitigate major revision differences. Most early JH dislocations were successfully treated closed, and conversely, the fewer early DM dislocations more often required revision.